Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Susanna Zavlunova"'
Publikováno v:
Vascular and Endovascular Surgery. 50:541-546
Objective: We describe a novel approach for the endovascular treatment of femoral artery occlusion as a result of Angio-Seal closure device deployment. Background: Angio-Seal is the most commonly used vascular closure device following percutaneous co
Publikováno v:
Cardiovascular revascularization medicine : including molecular interventions. 18(6)
Objective The evaluation of patency rates of intraluminal versus subintimal endovascular revascularization of long femoropopliteal (FP) lesions. Background Chronic total occlusions (CTO) of the FP artery in peripheral interventions are crossed either
Autor:
Gary S. Mintz, Anvar Babaev, Akiko Maehara, Brad J. Martinsen, Michael J. Attubato, Susanna Zavlunova
Publikováno v:
Vascular and Endovascular Surgery
Objective: The Tissue Removal Assessment with Ultrasound of the SFA and Popliteal (TRUTH) study assessed the performance of the orbital atherectomy system (OAS) to treat femoropopliteal arteries, including determining its effect on plaque removal. Me
Publikováno v:
Journal of the American College of Cardiology. 65(10)
Publikováno v:
Journal of the American College of Cardiology. 64(11)
Percutaneous removal of atherosclerotic material using atherectomy devices may offer an alternative approach for improving procedural success. The TRUTH study (24 patients) evaluated the removal of plaque with the Orbital Atherectomy System (OAS) (Ca
Publikováno v:
Journal of the American College of Cardiology. 64:B158
Publikováno v:
Journal of the American College of Cardiology. 61:E1809
Maintenance of long – term patency after implantation of Nitinol stent in the superficial femoral artery (SFA) remains to be one of the most challenging aspects of endovascular therapy. Studies have made conflicting observations regarding a possibl
Publikováno v:
Journal of the American College of Cardiology. (10):A1783
Publikováno v:
JACC: Cardiovascular Interventions. (2):S35
In-stent restenosis (ISR) in the superficial femoral artery (SFA) remains to be an Achilles heel of endovascular treatment of obstructive PAD. Stent fracture (SF) was identified as one of possible causes of ISR, but data on the role of SF in developm